Font Size:
a
A
A
Keyword [131I]
Result: 161 - 180 | Page: 9 of 10
161.
Clinical Efficacy And Risk Factors Of First
131
I Remnant Ablation In Patients With Differentiated Thyroid Carcinoma After Thyroidectomy
162.
Radioimmunoimaging And Treatment Effect Of
131
I Labeled RP215 McAb In Lung Adenocarcinoma-bearing Nude Mice Model
163.
A Retrospective Study Of
131
I-MIBG Radionuclide Planar Imaging Combined With SPECT/CT Fusion Imaging In The Diagnosis Of Adrenal Glands Diseases
164.
A Comparative Study Of Different Doses Of
131
I Remnant Ablation In Patients After Thyroidectomy For Intermediate Risk Differentiated Thyroid Cancer
165.
Correlation Between Time Of Taking Vitamin C And Salivary Glands Function In Thyroid Cancer Patients After
131
I Therapy
166.
The Role Of Molecular Imaging In The Management Of Differentiated Thyroid Cancer
167.
Studies On The Relationship Between Thyroglobulin Antibody And Malignant Degree Of Differentiated Thyroid Carcinoma And The Therapeutic Effect Of
131
I
168.
Dynamic Evaluation Of Therapeutic Effect Of 131I On Differentiated Thyroid Carcinoma And Its Influencing Factors
169.
Study On
131
I-Labeled CAERIN Peptide In Thyroid Cancer
170.
Effect Of The First Radioactivity Iodine Ablation On Pepsinogen For The Patients With Differentiated Thyroid Cancer
171.
Influence Factors Of Postoperative Thyroid Remnants And Its Relationship With 131I Effect In Differentiated Thyroid Cancer
172.
The Effect Of Vitamin E Pretreament On The Salivary Gland Function In Patients With Differentiated Thyroid Cancer For The First Thyroidectomy With
131
I Therapy
173.
Discussion On The Relationship Between Lower Level Of Ps-Tg And The Ratio Of Ps-Tg To TSH And Response To
131
I Therapy In Thyroid Papillary Carcinoma
174.
Effect Of
131
I Treatment After Surgery On The Function Of Parathyroid In Differentiated Thyroid Carcinoma
175.
Analysis Of The Clinical Therapeutic Effect And Related Factors In
131
I Treatment Of Graves’ Disease In The Border Area Of Guangxi,Yunnan And Guizhou
176.
Efficacy And Recurrence Rate Of Different Doses Of
131
I For Remnant Ablation In Low-and Intermediate-risk Differentiated Thyroid Cancer:A Meta-analysis
177.
Medically-derived iodine-131 as a tracer in aquatic environments
178.
Determination of Iodine-131 Uptake in Fucus gardneri Using Gamma-Ray Spectroscopy
179.
Uncertainty of inhalation dose coefficients for representative physical and chemical forms of iodine-131
180.
Risk Factors of Salivary Gland Dysfunction in Radioiodine Treated Thyroid Cancer Patients and Automation of SPECT/CT Imaging Analysis of Mouse Thyroi
<<First
<Prev
Next>
Last>>
Jump to
